CME Group Inc. Stock
CME Group Inc. Stock
CME Group Inc. shows a slight decrease today, losing -€0.350 (-0.150%) compared to yesterday.
Our community is currently high on CME Group Inc. with 20 Buy predictions and 9 Sell predictions.
With a target price of 257 € there is a slightly positive potential of 10.59% for CME Group Inc. compared to the current price of 232.4 €.
Our community identified positive and negative aspects for CME Group Inc. stock for the coming years. 1 users see the criterium "EBIT growth" as a plus for the CME Group Inc. stock. On the other hand our users think that "Expected dividend yield" could be a problem in the future.
Pros and Cons of CME Group Inc. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CME Group Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CME Group Inc. | -0.150% | -3.308% | -2.822% | 2.582% | 4.921% | 38.465% | 53.460% |
| MarketAxess Holdings | -0.420% | 2.794% | -2.108% | -37.627% | -34.814% | -47.205% | -69.707% |
| Nasdaq OMX Group Inc. | -0.620% | 0.260% | 2.293% | 0.508% | 3.127% | 26.962% | 117.941% |
| Intercontinental Exchange Inc. | -0.610% | -0.207% | 4.703% | -8.591% | -5.452% | 36.365% | 48.264% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-18
Upon first examination of the financial statements for CME Group (ticker: CME), a company from the Investment Banking and Investment Services industry, it appears that the company maintains a solid financial foundation. It is evident that the company has experienced substantial growth over the years, expanding in key financial areas such as assets, revenues, and net income.
*Pros: *
Growth in total assets: CME Group has consistently grown its total assets from 124.6 billion USD in 2020 to 174.1 billion USD in 2022. The growth is driven by both current and non-current assets. The increase in current assets can signal an enhanced liquidity position for the company.
Comments
CME Group (NASDAQ:CME) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $264.00 to $263.00. They now have a "sell" rating on the stock.
Show more
Ratings data for CME provided by MarketBeat
CME Group (NASDAQ:CME) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $263.00 to $264.00. They now have a "sell" rating on the stock.
Show more
Ratings data for CME provided by MarketBeat
CME Group (NASDAQ:CME) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $300.00 to $310.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CME provided by MarketBeat